Posted in | News | Gold | Mining Business

Globex Mining Plans Exploration Program on Montalembert Property

GLOBEX MINING ENTERPRISES INC. is pleased to update shareholders as regards planned work to be undertaken by Enforcer Gold Corp. on Globex's Montalembert, high grade gold property. (See Globex Press Releases dated Nov 17, 2016, Dec 20, 2016, March 31, 2017).

An airborne VLF-EM survey was flown over the property in March to help define structural features such as folding, shearing and faulting which may control the emplacement of gold mineralization.

A comprehensive field program is now planned including:

  • Extending stripping, previous undertaken by Globex, along strike in both directions on the Galena and Number 2 quartz/gold bearing veins.
  • Undertaking channel sampling along the newly exposed vein extensions
  • Performing IP surveys over the known vein systems
  • Doing prospecting over the property
  • Ground follow-up of airborne geophysical anomalies.
  • 5,000 to 8,000 meters of large diameter diamond drilling.
  • Targeted 1,000 meters of reverse circulation drilling.

The drilling will initially be targeted at four high priority areas. Enforcer has committed over $2.2 million to the 2017 exploration program.

Globex has optioned 100% interest in the Montalembert property to Enforcer in exchange for $2.7 million in option payments, 8.5 million Enforcer shares and $15 million in exploration expenditures over a 4 year period. Should Enforcer acquire the property, Globex will retain a Gross Metal Royalty of 6% on the first 150,000 ounces of gold produced (9,000 ounces) and 3.5% GMR thereafter.

This press release was written by Jack Stoch, P. Geo., President and CEO of Globex in his capacity as a Qualified Person (Q.P.) under NI 43-101

We Seek Safe Harbour.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.